Marshall Wace, LLP Mimedx Group, Inc. Transaction History

Marshall Wace, LLP

$77.3 Billion
Q3 2024

A detailed history of Marshall Wace, LLP transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 348,527 shares of MDXG stock, worth $3.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

348,527

Previous 298,818 16.64%

Holding current value

$3.3 Million

Previous $2.07 Million 0.53%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$5.65 - $7.76 $280,855 - $385,741	49,709 Added 16.64%	348,527 $2.06 Million
Q2 2024 Aug 14, 2024	BUY	$6.16 - $8.08 $19,853 - $26,041	3,223 Added 1.09%	298,818 $2.07 Million
Q1 2024 May 15, 2024	SELL	$7.61 - $8.63 $273,191 - $309,808	-35,899 Reduced 10.83%	295,595 $2.28 Million
Q4 2023 Feb 14, 2024	SELL	$5.7 - $9.14 $1.29 Million - $2.07 Million	-227,010 Reduced 40.65%	331,494 $2.91 Million
Q3 2023 Nov 14, 2023	BUY	$6.35 - $8.16 $2.07 Million - $2.66 Million	325,927 Added 140.14%	558,504 $4.07 Million
Q2 2023 Aug 14, 2023	SELL	$3.14 - $6.61 $282,468 - $594,622	-89,958 Reduced 27.89%	232,577 $1.54 Million
Q1 2023 May 15, 2023	BUY	$2.97 - $4.81 $957,928 - $1.55 Million	322,535 New	322,535 $1.1 Million
Q1 2021 May 17, 2021	SELL	$8.48 - $11.28 $1.28 Million - $1.7 Million	-150,447 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$5.32 - $10.17 $800,378 - $1.53 Million	150,447 New	150,447 $1.37 Million
Q1 2019 May 14, 2019	SELL	$1.84 - $3.74 $6.51 Million - $13.2 Million	-3,538,354 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.15 - $6.45 $4.07 Million - $22.8 Million	3,538,354 New	3,538,354 $6.33 Million

Others Institutions Holding MDXG

# of Institutions

209

Shares Held

98.2M

Call Options Held

Put Options Held

65.3K

View Full List

About MIMEDX GROUP, INC.

Ticker MDXG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 113,609,000
Market Cap $1.08B
Description
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...

More about MDXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Mimedx Group, Inc. Transaction History